Please sign in so that we can notify you about a reply
Indications
Haemorrhage; Patients with haemophilia undergoing dental extraction
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Active thromboembolic disease (e.g. pulmonary embolism, DVT, cerebral thrombosis), history or risk of thromboembolism (including retinal vein or artery occlusion); fibrinolytic conditions after consumption coagulopathy (unless predominant activation of the fibrinolytic system with acute severe bleeding), history of convulsions; acquired disturbances of colour vision. Severe renal impairment. Concomitant use with combined hormonal contraceptives.
Special Precautions
Patient with massive haematuria from the upper urinary tract, uncorrected CV or cerebrovascular disease, subarachnoid haemorrhage. Women with irregular menstrual cycle; not for use prior to menarche or post-menopause. Not recommended for use in patients with acute promyelocytic leukaemia taking oral tretinoin. Mild to moderate renal impairment. Pregnancy and lactation.
Storage
Store between 15-30°C.
MedsGo Class
Haemostatics
Features
Dosage
100 mg / ml (250 mg / 2.5 ml)
Ingredients
- Tranexamic Acid
Packaging
Solution for Injection (I.M./I.V.) 2.5ml x 1's
Generic Name
Tranexamic Acid
Registration Number
DR-4759
Classification
Prescription Drug (RX)
Product Questions
Questions
